Evaluating negative-symptom-like behavioural changes in developmental models of schizophrenia

Area of Science:

• Neuroscience
• Psychiatry
• Developmental Biology

Background:

• Schizophrenia has a significant developmental origin.
• Environmental factors during gestation, like maternal stress, infection, or malnutrition, can elevate schizophrenia risk.
• Neurodevelopmental models are crucial for understanding schizophrenia's origins and progression.

Purpose of the Study:

• To review and evaluate non-clinical neurodevelopmental models of schizophrenia.
• To assess the utility of these models in replicating behavioral deficits associated with schizophrenia's negative symptoms.
• To identify gaps in current research regarding negative symptom modeling.

Main Methods:

• Review of existing literature on neurodevelopmental models for schizophrenia.
• Analysis of models such as methylazoxymethanol (MAM) exposure, prenatal immune challenge, and neonatal ventral hippocampus lesions.
• Examination of studies assessing behavioral deficits, particularly those related to negative symptoms.

Main Results:

• Developmental models have been extensively validated for positive symptoms of schizophrenia.
• Few studies have evaluated these models for negative symptoms, primarily using social interaction tests.
• Aspects like anhedonia, affective flattening, and avolition are rarely studied in these models.

Conclusions:

• Current neurodevelopmental models are insufficient for comprehensively studying schizophrenia's negative symptoms.
• Further research is needed to develop and validate models that capture a broader range of negative symptomology.
• Enhanced characterization of these models with relevant pharmacological agents is necessary to improve their clinical relevance and therapeutic potential.